Abstract
BackgroundSince the introduction of poly (ADP-ribose) polymerase (PARP) inhibitors, BRCA testing has evolved as a standard management in epithelial ovarian cancer.ObjectiveTo analyze the implementation of molecular testing and PARP inhibitor...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have